VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $628,591 | -73.7% | 145,507 | -59.9% | 0.00% | -100.0% |
| Q2 2023 | $2,390,911 | -4.5% | 362,809 | -1.6% | 0.00% | 0.0% |
| Q1 2023 | $2,504,417 | -5.7% | 368,839 | +2.7% | 0.00% | 0.0% |
| Q4 2022 | $2,654,820 | -11.5% | 359,245 | +18.3% | 0.00% | 0.0% |
| Q3 2022 | $2,999,000 | -10.7% | 303,614 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $3,360,000 | -6.7% | 308,253 | -3.2% | 0.00% | 0.0% |
| Q1 2022 | $3,602,000 | -25.2% | 318,425 | +3.8% | 0.00% | 0.0% |
| Q4 2021 | $4,813,000 | -11.9% | 306,838 | -3.7% | 0.00% | 0.0% |
| Q3 2021 | $5,461,000 | -23.1% | 318,622 | -3.5% | 0.00% | -50.0% |
| Q2 2021 | $7,105,000 | +47.2% | 330,279 | +2.8% | 0.00% | +100.0% |
| Q1 2021 | $4,826,000 | +12.4% | 321,300 | -1.7% | 0.00% | 0.0% |
| Q4 2020 | $4,293,000 | +22.1% | 326,725 | -10.3% | 0.00% | 0.0% |
| Q3 2020 | $3,517,000 | -83.0% | 364,083 | -79.9% | 0.00% | -85.7% |
| Q2 2020 | $20,682,000 | +512.1% | 1,807,790 | +454.2% | 0.01% | +600.0% |
| Q1 2020 | $3,379,000 | -84.2% | 326,184 | -74.9% | 0.00% | -85.7% |
| Q4 2019 | $21,352,000 | +11.5% | 1,301,201 | -9.8% | 0.01% | +40.0% |
| Q3 2019 | $19,153,000 | -10.6% | 1,442,213 | -5.2% | 0.01% | -16.7% |
| Q2 2019 | $21,434,000 | -22.2% | 1,521,183 | +1.6% | 0.01% | -33.3% |
| Q1 2019 | $27,538,000 | +13.2% | 1,496,658 | +60.7% | 0.01% | 0.0% |
| Q4 2018 | $24,331,000 | +3105.7% | 931,171 | +2716.9% | 0.01% | – |
| Q3 2018 | $759,000 | -96.7% | 33,057 | -97.3% | 0.00% | -100.0% |
| Q2 2018 | $23,263,000 | +7.0% | 1,221,149 | -5.4% | 0.01% | 0.0% |
| Q1 2018 | $21,747,000 | +196.4% | 1,290,636 | +214.9% | 0.01% | +166.7% |
| Q3 2017 | $7,336,000 | +2378.4% | 409,835 | +2154.8% | 0.00% | – |
| Q2 2017 | $296,000 | -74.8% | 18,176 | -78.3% | 0.00% | – |
| Q1 2017 | $1,175,000 | -84.9% | 83,930 | -82.8% | 0.00% | -100.0% |
| Q4 2016 | $7,784,000 | +1870.6% | 488,025 | +1953.6% | 0.00% | – |
| Q3 2016 | $395,000 | +188.3% | 23,764 | +93.6% | 0.00% | – |
| Q2 2016 | $137,000 | -95.3% | 12,277 | -96.1% | 0.00% | -100.0% |
| Q4 2015 | $2,944,000 | -72.2% | 316,287 | -66.4% | 0.00% | -75.0% |
| Q3 2015 | $10,604,000 | -18.3% | 940,032 | -8.1% | 0.00% | -20.0% |
| Q2 2015 | $12,977,000 | +36.5% | 1,022,605 | +0.0% | 0.01% | +25.0% |
| Q1 2015 | $9,506,000 | -35.1% | 1,022,178 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $14,638,000 | +15.1% | 1,022,178 | -16.6% | 0.01% | +20.0% |
| Q3 2014 | $12,721,000 | -41.9% | 1,225,567 | -9.4% | 0.01% | -44.4% |
| Q2 2014 | $21,893,000 | -9.2% | 1,353,054 | -8.8% | 0.01% | -10.0% |
| Q1 2014 | $24,118,000 | +71.6% | 1,484,145 | +31.0% | 0.01% | +66.7% |
| Q4 2013 | $14,056,000 | +14.0% | 1,132,602 | +0.5% | 0.01% | +20.0% |
| Q3 2013 | $12,335,000 | +35.5% | 1,126,488 | -0.0% | 0.01% | +25.0% |
| Q2 2013 | $9,105,000 | – | 1,126,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |